CBIS News out -- Cannabis Science Expands 5-Year Agreement

New Post Public Reply Private Reply Replies (0) Message Board
stockseekerok
332
CBIS News out -- Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers
GlobeNewswire•February 2, 2018

IRVINE, CA , Feb. 02, 2018 (GLOBE NEWSWIRE) --

Cannabis Science, Inc., (CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, has entered into an expanded 5-year, $1.8 million Research Collaboration Agreement (RCA) with Dana Farber Cancer Institute, Inc., encompassing operating procedures and related communication activities. The work will be focused on essentially the same clinical targets with expanded work parameters based on current laboratory success.

Cannabis Science’s current laboratory research forms part of an aggressive drug development pipeline targeting critical ailments from laboratory research to scientific publication that Cannabis Science is developing with its research partners. This strongly demonstrates and effects the Company’s strong commitment to cutting-edge cannabinoid science in its pharmaceutical development programs. Cannabis Science has developed this pipeline to ensure that the Company’s research work reaches the scientific community and the patients in a timely fashion.

“Currently our funded research focuses on the clinical applications of cannabinoids in cancer treatment and pain management, but we will expand our portfolio in the following significant directions: (a) we will investigate the effectiveness of cannabinoid treatment in an increasing array of cancers, especially difficult to treat cancers and those with high fatality rates, (b) we will develop novel targeted delivery methods in the use of cannabinoids, and (c) we will, with advances in bioinformatics, computer science, and pharmacology, explore the mechanisms of action of cannabinoids in the management of disease,” stated Dr. Allen A. Herman, CBIS’ Chief Medical Officer (CMO).

The CBIS/Dana-Farber relationship will leverage the collective experience and expertise of both organizations to jointly develop cannabinoid-based medications and associated delivery technologies for the treatment of cancers, and potentially other indications. “I am extremely excited about our expanded agreement with Dana-Farber,” stated Mr. Raymond C. Dabney, CBIS’ President, CEO, and Co-founder. “We now have a more comprehensive framework in place with Dana-Farber that will enable us to focus on the science of cannabinoids. We believe we are uniquely positioned to help push forward the research and development of cannabinoid-based medicines and delivery systems to treat cancers, and potentially other ailments.”

CBIS entered into an initial research agreement with Dana-Farber in January 2017, and a second agreement in April 2017. As a result of this collaboration, CBIS and Dana-Farber have published initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the cancer research journal, Frontiers in Oncology. This publication titled, "Nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids," addresses drug delivery, and highlights an innovative strategy to transport cannabinoids directly to cancer cells with minimal toxicities or side effects that have so far hampered clinical translation efforts.

"This publication reflects our initial work and we are assiduously working on using our drug delivery system to examine the effect of cannabinoids with and without radiation therapy on lung and pancreatic cancer. This work will form part of our applications to the FDA. As we continue this research, we will expand our pharmaceutical development program from farm to bedside," concluded Dr. Herman.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CJ BIO Bets on Better Taste for Cleaner Food Labels

Updated Category News Views 92

A bland reduced-salt sauce can wreck months of product development in one spoonful. That unglamorous reality sits underneath CJ BIO's November 17-19 appearance at Fi Europe 2026 in Frankfurt, where the company is pitching food makers on a simple but stubborn proposition: healthier-looking labels cannot come at the expense of taste. Flavor Is Still the Gatekeeper CJ BIO is...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 188

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Tactical Tomahawk Motor Deal Puts Propulsion in Focus

Updated Category News Views 227

A missile program lives or dies on unglamorous hardware, and solid rocket motors are about as unglamorous as it gets until somebody cannot build enough of them. Raytheon has awarded Ursa Major and Avio USA a joint contract to develop solid rocket motors for the U.S. Navy’s Tactical Tomahawk missile program. That is the whole headline, and it matters more than the thin...

Continue Reading
Knowles Expands Its Teacher Pipeline With 39 Fellows

Updated Category News Views 62

Thirty-Nine Teachers Is Not a Trivial Signal Thirty-nine new math and science teachers may not rattle public markets, but it says plenty about where the real strain sits in American education. The Knowles Teacher Initiative has named its 2026 Teaching Fellowship class, its largest ever, and the timing is dead serious: schools are still wrestling with recruiting and...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 74

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Teachers in Space Takes Its Classroom Model Orbital

Updated Category News Views 60

Two teachers strapped into a research flight may sound like a glossy space-age photo op, but the useful part of this plan sits back in the classroom with the students staring at the data. Teachers in Space wants to send two educators aboard a Virgin Galactic research flight expected in 2027, and it is raising $2 million to fund the broader educational program and mission....

Continue Reading
America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 117

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 112

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Marelli’s Two Awards Put Practical Auto Tech in Focus

Updated Category News Views 89

Two trophies in Novi do not fill an order book, but Marelli’s latest pair says something useful about where automotive suppliers are trying to earn their keep. The company collected a 2026 Automotive News PACE Award for HorizonView and a PACE Pilot Award for Affordable 5G RedCap at the November 17 ceremony. One is already deployed in production; the other is a...

Continue Reading
Cytonics Refines CYT-108 Trial Plan With Decade OA Data

Updated Category News Views 83

A Better Map Is Not a Working Drug Knee osteoarthritis has chewed up plenty of promising development plans because the disease moves at an aggravatingly uneven crawl. Cytonics has done something sensible before pushing deeper into CYT-108: it went back to long-term untreated patient data and asked which knees actually deteriorate fast enough for a trial to detect...

Continue Reading

Top 5 Most Recently Viewed Articles

UGREEN's NAS Launch: Is AI the Game-Changer or Just Hype?

Updated Category News Views 227

UGREEN announced its flagship AI NAS models on February 17, 2026, aiming to redefine private cloud data management with an active approach. Traders perked up when they heard about the iDX Series—specifically the UGREEN NASync iDX6011 and its Pro version. But here's where you should be asking tough questions: Can UGREEN really deliver amidst a crowded tech space? The...

Continue Reading
LRT Company Introduces $17 Million Senior Living Investment Deal

Updated Category News Views 133

LRT Company Unveils Innovative Senior Living Project In a significant move for the senior living sector, LRT Company has rolled out the LRT Hardeeville Senior Living DST. This cash-based offering aims to generate $17 million from accredited investors and presents a compelling opportunity to meet the growing demand for quality senior housing. Offering Details The LRT...

Continue Reading
Innovative Advances in Dendritic Cell Therapies for Cancer

Updated Category News Views 287

Groundbreaking Insights in Cancer Immunotherapy In an exciting development, Northwest Biotherapeutics (OTCQB: NWBO) plans to showcase significant advancements at the upcoming Frontiers in Cancer Immunotherapy Conference. Dr. Marnix Bosch, the company's Chief Technical Officer, will present a discussion titled "Next Generation Dendritic Cell Treatments to Improve...

Continue Reading
Scooter's Coffee: Celebrated among Leading US Franchises

Updated Category News Views 303

Scooter's Coffee Receives Esteemed Recognition in Franchise Rankings With over 850 locations spread across multiple states, Scooter's Coffee has secured a prominent position as one of the leading drive-thru coffee brands in the United States. The brand has been recognized for its impressive growth and community engagement, establishing itself as a favorite among coffee...

Continue Reading
Viatris Investors Urged to Act – Important Legal Deadline Approaches

Updated Category News Views 355

Viatris Class Action Lawsuit Updates Kahn Swick & Foti, LLC offers a timely reminder to investors who have suffered losses exceeding $100,000 in Viatris Inc. (NASDAQ: VTRS). The firm urges affected individuals to take note of the approaching deadline for lead plaintiff applications in light of the ongoing securities class action lawsuit involving the company....

Continue Reading